608 related articles for article (PubMed ID: 32620999)
1. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
[TBL] [Abstract][Full Text] [Related]
2. How Precision Medicine Is Changing Acute Myeloid Leukemia Therapy.
Heuser M; Mina A; Stein EM; Altman JK
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():411-420. PubMed ID: 31099617
[TBL] [Abstract][Full Text] [Related]
3. Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia.
Ribeiro S; Eiring AM; Khorashad JS
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680203
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic targeting and personalized approaches for AML.
Roboz GJ
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
[TBL] [Abstract][Full Text] [Related]
5. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
DiNardo C; Lachowiez C
Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
[TBL] [Abstract][Full Text] [Related]
6. [Gene mutations in acute myeloid leukemia].
Yamaguchi H
Rinsho Ketsueki; 2016; 57(12):2535-2542. PubMed ID: 28090023
[TBL] [Abstract][Full Text] [Related]
7. Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
Miyamoto K; Minami Y
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698349
[TBL] [Abstract][Full Text] [Related]
8. Development of Personalized Molecular Therapy for Acute Myeloid Leukemia.
Engen CB; Hajjar E; Gjertsen BT
Curr Pharm Biotechnol; 2016; 17(1):20-9. PubMed ID: 26420051
[TBL] [Abstract][Full Text] [Related]
9. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
[TBL] [Abstract][Full Text] [Related]
11. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
12. NPM1-mutated acute myeloid leukemia: from bench to bedside.
Falini B; Brunetti L; Sportoletti P; Martelli MP
Blood; 2020 Oct; 136(15):1707-1721. PubMed ID: 32609823
[TBL] [Abstract][Full Text] [Related]
13. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Relapsed Acute Myeloid Leukemia.
Thol F; Ganser A
Curr Treat Options Oncol; 2020 Jun; 21(8):66. PubMed ID: 32601974
[TBL] [Abstract][Full Text] [Related]
15. How I diagnose and treat NPM1-mutated AML.
Falini B; Brunetti L; Martelli MP
Blood; 2021 Feb; 137(5):589-599. PubMed ID: 33171486
[TBL] [Abstract][Full Text] [Related]
16. Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.
Wertheim GB; Hexner E; Bagg A
Mol Diagn Ther; 2012 Dec; 16(6):357-69. PubMed ID: 23184342
[TBL] [Abstract][Full Text] [Related]
17. 'Acute myeloid leukemia: a comprehensive review and 2016 update'.
De Kouchkovsky I; Abdul-Hay M
Blood Cancer J; 2016 Jul; 6(7):e441. PubMed ID: 27367478
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
[TBL] [Abstract][Full Text] [Related]
19. [Acute myeloid leukemia: molecular pathogenesis and new therapeutic strategies].
Goyama S
Rinsho Ketsueki; 2016 Feb; 57(2):118-28. PubMed ID: 26935629
[TBL] [Abstract][Full Text] [Related]
20. Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children.
Masetti R; Bertuccio SN; Guidi V; Cerasi S; Lonetti A; Pession A
Future Oncol; 2020 Nov; 16(33):2747-2762. PubMed ID: 32813587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
